Visionaries from Merck, Syneos Health and Accenture joined Generis for a live video discussion of the latest trends influencing the way life sciences companies manage Quality – and what future lies ahead for the discipline. They considered what measures could be taken now to enable more efficient end-to-end processes – including the preempting and minimisation of Quality issues using AI/ machine learning technology.